Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.9 USD | +0.77% |
|
+8.11% | -2.37% |
15/07 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
15/07 | Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.37% | 4.12TCr | |
+22.15% | 4.66TCr | |
+45.43% | 4.17TCr | |
+33.84% | 3.24TCr | |
-6.35% | 2.81TCr | |
+20.42% | 2.82TCr | |
+48.83% | 1.45TCr | |
+45.00% | 1.37TCr | |
+0.06% | 1.22TCr | |
-8.52% | 1.11TCr |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating